Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Brain sciences·2026
Same author

A neurologist's guide to VEXAS syndrome: Differentiating somatic autoinflammation from autoimmune mimics.

Intractable & rare diseases research·2026
Same author

Exploring the Personalisation of Digital Cognitive Rehabilitation in Multiple Sclerosis Through Wearable Data and Machine Learning.

Studies in health technology and informatics·2026
Same author

Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.

Frontiers in public health·2026
Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026

Related Experiment Video

Updated: Jun 6, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

Inflammatory changes induced by transplanted neural precursor cells in a multiple sclerosis model.

Angeliki Giannakopoulou1, Nikolaos Grigoriadis, Eleni Polyzoidou

  • 1Second Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Macedonia, Greece.

Neuroreport
|December 15, 2010
PubMed
Summary

Neural precursor cell (NPC) transplantation improved multiple sclerosis symptoms by reducing brain inflammation. However, effects on spinal cord inflammation were limited, suggesting localized immunosuppression and bystander neuroprotection are key therapeutic mechanisms.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Neural precursor cell (NPC) transplantation is investigated for multiple sclerosis (MS) therapy.
  • Evidence suggests NPCs exert therapeutic effects via immunomodulation rather than direct cell replacement.

Purpose of the Study:

  • To investigate the therapeutic effects of intraventricularly transplanted NPCs in a mouse model of multiple sclerosis.
  • To determine the impact of NPC transplantation on central nervous system inflammation and clinical symptoms.

Main Methods:

  • Induction of experimental autoimmune encephalomyelitis (EAE) in mice.
  • Intraventricular transplantation of NPCs.
  • Assessment of clinical symptoms, brain and spinal cord inflammation, and inflammatory cell apoptosis.

Main Results:

  • Intraventricular NPC transplantation improved clinical symptoms and suppressed brain inflammation by enhancing inflammatory cell apoptosis.
  • NPC treatment did not significantly reduce inflammatory cells in the spinal cord.
  • Inflammation in the spinal cord is a major determinant of EAE clinical manifestation.

Conclusions:

  • The therapeutic effect of intraventricular NPC transplantation in EAE is likely due to localized immunosuppression in the brain.
  • Bystander neuroprotective mechanisms triggered by NPC transplantation may account for the observed therapeutic benefits.
  • NPC therapy's efficacy may depend on the targeted location and the specific inflammatory environment.